BioPharmSignal logoBioPharmSignal

Biotech News

Xtant Medical Reports Third Quarter 2025 Financial Results

Xtant Medical (XTNT)Xtant MedicalEarnings

Total Revenue of $33.3 Million Increased 19% Year-over-Year Delivers Positive Net Income, Adjusted EBITDA and Operating Cash Flow Reiterates FY25 Revenue Guidance of $131-$135 Million , Representing Growth of 11%-15% over FY24 Previously Announced Sale of Certain Hardware Assets and OUS

Related news

XTNTXtant Medical2026-08-11 11:00 EST

Xtant Medical Reports Second Quarter 2026 Financial Results

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

FEMYFEMASYS2026-08-14 20:05 EST

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

PAVMPAVmed2026-08-13 12:00 EST

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

XAIRBeyond Air2026-08-13 11:00 EST

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

ICUSeaStar Medical2026-08-12 20:05 EST

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

STIMNeuronetics2026-08-11 11:50 EST

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

NEPHNephros2026-08-06 20:10 EST

Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026

CVRXCVRx2026-08-06 20:05 EST

CVRx Reports Second Quarter 2026 Financial and Operating Results

APYXApyx Medical2026-08-06 20:05 EST

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

View all latest news

Xtant Medical

Orthopedic Surgical Products Company Xtant Medical develops and distributes surgical products for spinal and other orthopedic procedures. Biologics and Implants The portfolio includes bone grafts, biologic materials, spinal fixation systems, and related surgical instruments. Hemostasis Expansion An exclusive U.S. distribution agreement...

Recent company news

XTNTXtant Medical2026-08-11 11:00 EST

Xtant Medical Reports Second Quarter 2026 Financial Results

XTNTXtant Medical2026-08-06 12:00 EST

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

XTNTXtant Medical2026-08-04 20:05 EST

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

XTNTXtant Medical2026-05-13 11:00 EST

Xtant Medical Reports First Quarter 2026 Financial Results

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Stock data

Close
0.32 USD
Market cap
65.22M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States